2026 BD opportunity scan for Beijing Tide Pharmaceutical Co., Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreach

2026 BD opportunity scan for Beijing Shuoxing Biomedical Technology Co. Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and

2026 BD opportunity scan for Beijing Northland Biotech.Co., Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreach ra

2026 BD opportunity scan for Beijing Minhai Biological Technology Co., Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and

2026 BD opportunity scan for Beijing Luzhu Biopharmaceutical Co., Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outre

2026 BD opportunity scan for Beijing Kexing Zhongwei Biotechnology Co. Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and

2026 BD opportunity scan for Beijing Jinchengtaier Pharmaceutical Co., Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and

2026 BD opportunity scan for Beijing Danqing Pharmaceutical Technology Co., Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals

2026 BD opportunity scan for Beijing Biotech: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreach rationale.

2026 BD opportunity scan for BeBetter Med, Inc.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreach rationale.

2026 BD opportunity scan for Bcy Pharm Co, Ltd: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreach rationale.

2026 BD opportunity scan for Bayer Healthcare Co., Ltd.: pipeline stage, evidence package, IP risk, deal precedent, financial signals and outreach rationale.